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 Introduction 
 Hyper IgE syndromes (HIES) are rare primary immu-
nodeficiency disorders characterized by the clinical triad 
of recurrent cutaneous abscesses, recurrent pneumonia 
and elevated levels of serum IgE  [1] . HIES can be inher-
ited as an autosomal dominant or recessive trait, how-
ever, most patients are sporadic. In addition to the afore-
mentioned classical triad, HIES patients suffer of several 
other symptoms including progressive skeletal deformi-
ties and pathologic fractures, delayed secondary denti-
tion, eczema, neonatal rash and autoimmune manifesta-
tions  [1, 2] . The underlying pathogenesis of HIES still re-
mains elusive, despite 4 decades of research since HIES 
was first described  [3] . Recently, the gene encoding  Tyk2 , 
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 Abstract 
 Hyper IgE syndromes (HIES) are primary immunodeficiency 
disorders of unknown pathogenesis. Patients are typically af-
fected with ‘cold’ abscesses of the skin, recurrent cyst-form-
ing pneumonia, chronic mucocutaneous candidiasis and oth-
er less frequent features such as progressive skeletal 
abnormalities. Defective signaling in the Toll-like receptor 
(TLR) pathways has been suggested as a responsible patho-
logic mechanism, however, in previous reports, 10 patients 
revealed no defect in inflammatory cytokine responses to dif-
ferent TLR ligands. Here, we report the increase in pro-inflam-
matory cytokines TNF-  and IL-8, following TLR2 and TLR4 
stimulation in a larger cohort of 25 additional patients with 
HIES, and provide a meta-analysis of the TLR data in HIES. 
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a member of the JAK tyrosine kinase family, was shown 
to be mutated in a single patient with an autosomal reces-
sive HIES-like phenotype  [4, 5] .
 Toll-like receptors (TLRs) have been shown to play an 
important role in innate immunity. The TLRs are pattern-
recognition receptors that collectively recognize lipid, 
carbohydrate, peptide and nucleic acid structures that are 
broadly expressed by different groups of microorganisms 
 [6] . A defective TLR signaling pathway has been associ-
ated with primary vulnerability to a broad range of bac-
teria and viruses in animal models. In contrast, human 
IRAK-4 deficiency  [7] and MyD88 deficiency [pers. com-
mun.] present with a relatively narrow susceptibility to 
infections with pyogenic bacteria, most prominently 
 Streptococcus pneumoniae and  Staphylococcus aureus . 
Deficiency in UNC-93B, which interacts with the nucleo-
tide receptors TLR3, 7, 8 and 9, causes particular suscep-
tibility to  Herpes simplex virus 1 infections  [8] . Interest-
ingly,  S. aureus is the major responsible pathogen for skin 
abscesses and pneumonia in HIES, prompting us to inves-
tigate TLR signaling in patients with a HIES phenotype.
 To date, 2 reports on a limited number of patients have 
failed to reveal defects in TLR signaling in HIES patients 
 [9, 10] . In addition, both studies showed that in HIES pa-
tients pro-inflammatory cytokines are secreted at least in 
similar amounts compared to normal controls, a finding 
somewhat surprising given that the hallmark of HIES is 
the absence of inflammation (lack of warmth of abscess-
es and fevers in severely ill patients). However, given the 
heterogeneity of the syndrome and the fact that the 2 pre-
vious studies were limited to a total of 10 patients, the 
published data could not sufficiently rule out defects in 
TLR signaling in HIES. Accordingly, we here report on 
TLR responses in a larger group of 25 HIES patients, who 
were collected through an international network. Fur-
thermore, we provide a meta-analysis summarizing the 
data of all 3 reports on the inflammatory response to TLR 
stimulation in HIES.
 Methods 
 Patients 
 Patients with the diagnosis of autosomal dominant or sporad-
ic HIES were evaluated according to the National Institute of 
Health scoring system  [11] . Patients with scores between 19 and 
65 points were included into the study to cover most possible phe-
notypes observed in this heterogeneous disease. Patients were en-
rolled at their respective clinical center. Ethical approval was ob-
tained from the Ethics Committee of the Freiburg University 
Hospital (protocol No. 239/99 to B.G.).
 Cytokine levels in 25 patients’ samples, including 12 males and 
13 females, were compared to control samples from 15 sex- and 
age-matched healthy volunteers.
 TLR Stimulation and Cytokine Assay 
 Whole blood EDTA samples were sent from participating cen-
ters to Freiburg with an overnight carrier. Peripheral blood mono-
nuclear cells (PBMCs) were then immediately prepared without 
delay and specifically without freezing the cells. Human PBMCs 
were isolated by gradient centrifugation on Histopaque 1077 (Sig-
ma-Aldrich) according to the manufacturer’s protocol. The cells 
were resuspended in RPMI 1640 medium containing 10% FBS 
and plated at a density of 2  ! 10 6 /ml in a 96-well dish. PBMCs 
were stimulated with the following reagents. Lipopolysaccharide 
(LPS) derived from  Escherichia coli strain 0111:B4 (Sigma-Al-
drich) was twice re-extracted by phenol chloroform. A clinical 
isolate of  S. aureus was grown on blood agar plates (Remel). Bac-
terial colonies were removed from the plates after overnight cul-
ture, washed 3 times in PBS, and then used to inoculate RPMI and 
grown to midlog phase (ABS650 = 0.27–0.30). Subsequently, bac-
teria were harvested by centrifugation and ethanol inactivated 
(70% ETOH, 45 min, on ice), washed and resuspended in pyro-
gen-free water at a concentration of 20 mg/ml (corresponding to 
approximately 1  ! 10 10 bacteria/ml as determined by CFU/ml 
before inactivation). Peptidoglycan from  S. aureus was purchased 
from Sigma. Peptidoglycan was essentially free of LPS, since it did 
not activate TLR2 –/– mouse macrophages that respond to LPS 
concentrations as low as 100 pg/ml. After addition of the indi-
cated preparations, incubation proceeded for an additional 16 h 
at 37 ° C and 5% CO 2 . Supernatants were collected and stored at 
–80 ° C until assayed with a commercial ELISA for human TNF-  
and IL-8 (R&D Systems).
 Wilcoxon W and Mann-Whitney U statistical tests were used 
to examine the results. p values less than 0.05 were considered 
significant.
 Results 
 PBMC from 25 patients with the diagnosis of HIES 
were isolated and stimulated with  S. aureus  extracts, LPS 
derived from  E. coli and peptidoglycan. After stimula-
tion, culture supernatants were assayed for human TNF-
  and IL-8 production by ELISA.
 None of the patients had a loss of TNF-  or IL-8 pro-
duction, indicating that in all patients tested, the TLR 
signaling pathway was not grossly defective. In fact, 
TNF-  production by patient cells was increased com-
pared to controls in response to LPS,  S. aureus and pep-
tidoglycan stimulation ( table 1 ). However, the rise in 
TNF-  level was significant only at higher concentra-
tions of 10 ng/ml for LPS and at 1  ! 10 8 CFU/ml for  S. 
aureus ( fig. 1 ; p  ! 0.05). IL-8 production after stimula-
tion did not statistically differ between patients and con-
trols ( table 1 ;  fig. 2 ).
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 We then attempted to perform a meta-analysis on 
TNF-  response with the data from previous studies  [9, 
10] . However, due to differences in the study design, only 
data from the study by Hawn et al.  [9] could be compared 
with our data. In addition, it may be worth mentioning 
that the data by Hawn et al.  [9] were obtained by a whole 
blood assay, whereas our data were collected by studying 
PBMCs. The combined analysis confirmed that TNF-  
levels were considerably higher in patients than controls 
when stimulated with LPS 10 ng/ml (3,257 vs. 1,240 pg/
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 Fig. 1. TNF-  response to various TLR ligands at different concentrations: LPS at 1 and 10 ng/ml,  S. aureus at 
10 7 and 10 8 CFU/ml and peptidoglycan (PG) at 3   g/ml. p  ! 0.05 for LPS at 10 ng/ml and for  S. aureus at 10 8 
CFU/ml. Boxes represent values between the 25th and 75th percentiles. The horizontal lines correspond to the 
median, minimum and maximum. 
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 Fig. 2. IL-8 response to various TLR ligands at different concentrations: LPS at 1 and 10 ng/ml,  S. aureus at 10 7 
and 10 8 CFU/ml and peptidoglycan (PG) at 3   g/ml. Boxes represent values between the 25th and 75th percen-
tiles. The horizontal lines correspond to the median, minimum and maximum. 
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ml, p = 0.006),  S. aureus  1  ! 10 8 CFU/ml (9,024 vs. 2,430 
pg/ml, p = 0.001) and peptidoglycan 3   g/ml (3,270 vs. 
1,718 pg/ml, p = 0.004).
 Discussion 
 We have evaluated the TNF-  and IL-8 response to 
various TLR ligands, and found it not to be deficient in 
cells from HIES patients. In contrast, we found that pro-
duction of TNF-  was significantly increased following 
TLR2 and TLR4 stimulation.
 Classical HIES is characterized by ‘cold’ skin abscess-
es and a lack of inflammation in patients. At the same 
time, the disorder has features which indicate a general-
ized inflammatory process. In addition, retained prima-
ry teeth and progressive skeletal malformations suggest 
defective osteohomeostasis.
 TNF-  is a pro-inflammatory cytokine that acts as a 
key molecule in different inflammatory diseases  [12] . In 
addition, it has been shown that TNF-  induces apoptosis 
in osteoblast and inhibits their differentiation  [13, 14] .
 Furthermore, it has previously been shown that over-
expression of  Btk , a member of Tec family tyrosine ki-
nases, enhances TNF-  and not IL-8 production in re-
sponse to TLR2 and TLR4 ligands  [15] . Given the differ-
ent requirements of TLR signaling for cytokine pro-
duction, the higher levels of pro-inflammatory cytokines 
in HIES might be due to an accessory pathway, as previ-
ously suggested  [10] .
 In conclusion, we show that patients with HIES do not 
have a deficient TLR signaling pathway. In contrast, we 
found that mononuclear cells respond with increased 
TNF-  formation to TLR stimulation. Hence, an imbal-
anced inflammatory response to microbial stimuli might 
account in part for the pathology associated with HIES.
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Table 1. Median of TNF- and IL-8 production levels in response to TLR stimulation
Stimulants TNF-, pg/ml IL-8, pg/ml
patients controls p value patients controls p value
LPS 1 ng/ml 691 446 0.175 55,400 45,600 0.357
LPS 10 ng/ml 3,257 1,418.5 0.043 79,800 67,500 0.292
S. aureus 1 ! 107 CFU/ml 5,434.5 5,372 0.726 140,800 119,000 0.299
S. aureus 1 ! 108 CFU/ml 11,520 5,806 0.038 174,741.5 107,500 0.252
Peptidoglycan 3 g/ml 3,550.5 2,023.5 0.085 120,900 135,090 0.557
p values were calculated by nonparametric Mann-Whitney U tests.
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